In this study, we have designed a reference standard to develop an optimal reaction system for TCR beta chain (TRB) amplification, and then, we used this system to analyze the changes in TRB repertoire in acute ALL patients during chemotherapy. Here, THRB is linked to acute lymphoblastic leukemia.